Similarly, verapamil is another drug candidate for COPD and is a calcium channel blocker which attaches to the alpha-subunits of L-type calcium channels and thus inhibits the pathway of calmodulin and CaM kinase from the mucin genes. Here, MUC5AC is linked to chronic obstructive pulmonary disease.